Doxazosin - 0615-5537-39 - (Doxazosin mesylate)

Alphabetical Index


Drug Information of Doxazosin

Product NDC: 0615-5537
Proprietary Name: Doxazosin
Non Proprietary Name: Doxazosin mesylate
Active Ingredient(s): 8    mg/1 & nbsp;   Doxazosin mesylate
Administration Route(s): ORAL
Dosage Form(s): TABLET
Coding System: National Drug Codes(NDC)

Labeler Information of Doxazosin

Product NDC: 0615-5537
Labeler Name: NCS HealthCare of KY, Inc dba Vangard Labs
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA075509
Marketing Category: ANDA
Start Marketing Date: 20001019

Package Information of Doxazosin

Package NDC: 0615-5537-39
Package Description: 30 TABLET in 1 BLISTER PACK (0615-5537-39)

NDC Information of Doxazosin

NDC Code 0615-5537-39
Proprietary Name Doxazosin
Package Description 30 TABLET in 1 BLISTER PACK (0615-5537-39)
Product NDC 0615-5537
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Doxazosin mesylate
Dosage Form Name TABLET
Route Name ORAL
Start Marketing Date 20001019
Marketing Category Name ANDA
Labeler Name NCS HealthCare of KY, Inc dba Vangard Labs
Substance Name DOXAZOSIN MESYLATE
Strength Number 8
Strength Unit mg/1
Pharmaceutical Classes Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]

Complete Information of Doxazosin


General Information